Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2731]

Blocking tumour signals can hinder cancer's spread

Blocking tumour signals can hinder cancer's spread

Study could lead to new scale for stratifying neuroblastoma risk

Study could lead to new scale for stratifying neuroblastoma risk

FDA approves nivolumab plus ipilimumab and chemotherapy for first-line treatment of metastatic NSCLC

FDA approves nivolumab plus ipilimumab and chemotherapy for first-line treatment of metastatic NSCLC

Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma

Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma

Platinum-based chemo may improve survival for some metastatic pancreatic cancer patients

Platinum-based chemo may improve survival for some metastatic pancreatic cancer patients

Researchers identify therapeutic targets to prevent cancer-associated muscle loss

Researchers identify therapeutic targets to prevent cancer-associated muscle loss

Novel biomarkers predict benefit with immunotherapy in metastatic breast cancer

Novel biomarkers predict benefit with immunotherapy in metastatic breast cancer

Just a little physical activity pays big dividends to high risk breast cancer patients

Just a little physical activity pays big dividends to high risk breast cancer patients

ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metastatic triple-negative breast cancer

ASCO 2020: Pembrolizumab plus chemotherapy demonstrated improvement in PFS for patients with metastatic triple...

ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma

ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma

More from ecancer